close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

28.09 -0.46 (-1.61%)
Delayed Quote Updated: 10:25 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
What Enovis (ENOV) Said on Its Q3 Earnings Call ↗
Enovis (NYSE:ENOV) reported third-quarter sales of $559 million and raised its full-year adjusted earnings outlook, as growth in its reconstructive business and improved cash generation helped offset... 
Via MarketBeat
Topics Earnings
News headline image
ENOV Q3 2026 deep dive: product innovation and share gains amid market volatility
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q3 2026, with sales up 1.8% year on year to $558.7 millio... 
Via StockStory
News headline image
Enovis Corp (ENOV) Q3 2026 Earnings Call Transcript ↗
Margins widened and guidance moved higher despite regional headwinds. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Why are Enovis (ENOV) shares soaring today
What happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 16.5% in the morning session after the company reported third-quart... 
Via StockStory
News headline image
Enovis’s (NYSE:ENOV) Q3 2026 earnings results: revenue in line with expectations, stock soars
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q3 2026, with revenue up 1.8% year on year to $558.7 mill... 
Via StockStory
News headline image
ENOVIS Announces Third Quarter 2026 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
iRhythm, ICU Medical, Globus Medical, Enovis, and CONMED shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
Earnings to watch: Enovis (ENOV) reports Q3 results tomorrow
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market open. Here’s what you need to know. Enovis m... 
Via StockStory
News headline image
1 value stock worth investigating and 2 we question
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
1 Unprofitable Stock on Our Buy List and 2 We Turn Down
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
2 Stocks Under $50 Worth Your Attention and 1 We Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
3 Healthcare Stocks We Find Risky
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on... 
Via StockStory
News headline image
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
From Enovis Corporation
Via GlobeNewswire
News headline image
1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
3 Small-Cap Stocks We Approach with Caution
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo... 
Via StockStory
News headline image
2 Russell 2000 Stocks on Our Watchlist and 1 We Brush Off
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Shareholders of Enovis would probably like to forget the past six months even happened. The stock dropped 20.4% and now trades at $18.67. This may have inves... 
Via StockStory
Topics Artificial Intelligence
News headline image
Insider at Medical Device Maker Buys More Than 7,500 Shares ↗
Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including En... 
Via StockStory
News headline image
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal ↗
Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its... 
Via MarketBeat
News headline image
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
3 Stocks Under $50 We Approach with Caution
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Enovis Q2 Earnings Call Highlights ↗
Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding... 
Via MarketBeat
Topics Earnings Economy
News headline image
Why Enovis (ENOV) Shares Are Sliding Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) fell 12.8% in the afternoon session after the company reported second-quar... 
Via StockStory
News headline image
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.2% year on year to $582.8 mill... 
Via StockStory
News headline image
Enovis Announces Second Quarter 2026 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis (ENOV) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday morning. Here’s what to expect. Enovis beat analysts’ reve... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.